US FDA Collects ‘Majority’ Of PDUFA Program Fees After Payment Plea
Executive Summary
The revenue is expected to sustain the prescription drug user fee program moving forward after reserves were tapped at the start of fiscal year 2023.
You may also be interested in...
FDA Reforms Missed By FDORA Could Find Vehicle In Animal Drug User Fee, Pandemic Bills
The usually lower-profile user fee reauthorizations could gain more attention for broader US FDA issues, said Andi Lipstein Fristedt, FDA deputy commissioner for policy, legislation and international affairs.
User Fee Carryover Funds Again Decrease Potential Furloughs In US FDA Shutdown Plan
More than 80% of FDA employees would continue working during a government shutdown, which appears unlikely as congressional negotiators announce a ‘framework’ agreement.
US FDA Shutdown Plan Decreases Potential Furloughs Again, Thanks To User Fee Carryover Funds
More than 80% of FDA employees would continue working during a government shutdown, which appears unlikely as congressional negotiators announce a ‘framework’ agreement.